Table 4.
Comparison of coagulation indicators between patients with mild and severe patients with COVID-19 infection.
| Normal range | Patients with mild disease (n = 30) | Patients with severe disease (n = 30) | p-value | F | |
|---|---|---|---|---|---|
| PT (s) | 10.5–13.5 | 12.05 ± 0.63 | 13.3 ± 1.36 | <0.001 | 59.902 |
| PT (%) | 75–125 | 74.23 ± 9.19 | 95.59 ± 12.08 | <0.001 | 4.433 |
| APTT (s) | 21–37 | 26.96 ± 3.57 | 27.82 ± 3.72 | 0.228 | 0.141 |
| TT (s) | 13–21 | 16.62 ± 3.7 | 16.6 ± 3.24 | 0.967 | 1.793 |
| INR | 0.8–1.2 | 1 ± 0.12 | 1.02 ± 0.14 | 0.603 | 4.048 |
| Fibrinogen (g/L) | 2–4 | 3.35 ± 0.75 | 2.60 ± 0.59 | <0.001 | 5.788 |
| AT-3 (%) | 75–125 | 88.14 ± 4.29 | 73.73 ± 5.77 | <0.001 | 6.226 |
| D-dimer (mg/L) | 0–1.5 | 2.43 ± 0.65 | 5.54 ± 2.36 | <0.001 | 99.096 |
| FDP (μg/ml) | 0–5 | 2.37 ± 0.66 | 70.15 ± 30.47 | <0.001 | 117.06 |